Breaking News, Financial News

Financial Report: Abbott 1Q

Worldwide pharmaceutical sales were $3.6 billion (-6%). Humira sales were $1.0 billion (+17%).

Abbott 1Q

1Q Revenues: $6.7 billion (-1%)

1Q Earnings: $1.4 billion(+53%)

Comments: Worldwide pharmaceutical sales were $3.6 billion (-6%).
Humira sales were $1.0 billion (+17%). Kaletra sales dropped 17% to $292 million, while Depakote sales were down 65% to $129 million due to generic competition. TriCor/Trilipix sales were $253 million (+3%). Worldwide vascular sales were $645 million (+43%) with Coronary Stent sales up 112% to $402 million.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters